Analysts fell to the sidelines weighing in on Passage Bio (PASG) and Esperion (ESPR) with neutral ratings, indicating that the experts are neither ......

Esperion Therapeutics (ESPR) has disclosed a new risk, in the Regulation category. The discussion emphasizes that Esperion Therapeutics’ Form 10-Q ......

Analysts are intrested in these 5 stocks: ( ($EXE) ), ( ($IP) ), ( ($ESPR) ), ( ($CMPS) ) and ( ($TNXP) ). Here is a breakdown of their recent ...

Esperion received a Hold rating and price target from Needham analyst Serge Belanger today. According to TipRanks, Belanger is a 5-star analyst wit......

Analysts are intrested in these 5 stocks: ( ($ESPR) ). Here is a breakdown of their recent ratings and the rationale behind them. Esperion Therapeu......

Esperion ( ($ESPR) ) just unveiled an announcement. On May 1, 2026, Esperion announced a definitive agreement under which funds managed by healthca......